BLU -U BLUE LIGHT PHOTODYNAMIC THERAPY ILLUMINATOR
Sun Pharmaceutical Industries, Inc. · Decision date Dec 3, 1999
What did the FDA approve?
FDA records P990019 as an original PMA application. The recorded decision is approval, dated Dec 3, 1999.
FDA approval order statement
The devices is indicated for use in Photodynamic Therapy with Levulan Kerastick (aminolevulinic acid HCl) for Topical Solution, 20% for the treatment of non-hyperkeratotic actinic keratoses of the face or scalp.
- Regulatory pathway
- Original PMA
- Clinical specialty
- General, Plastic Surgery
- Decision date
- Dec 3, 1999
Regulatory record facts
- Identifier
- P990019
- Regulatory pathway
- Premarket approval application
- Applicant
- Sun Pharmaceutical Industries, Inc.
- Product code
- MVF
- Decision code
- APPR
- Decision date
- Dec 3, 1999
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: System, laser, photodynamic therapy.
- Applicant
- Sun Pharmaceutical Industries, Inc.
- Product code
- MVF
- FDA device class
- 3
The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.
FDA decision timeline
P990019 received
Application receipt date recorded by FDA.
P990019 · FDA decision
APPR
P990019/S010 · Related supplement
BLU-U Blue Light Photodynamic Therapy Illuminator (Model 4170E)
Timeline entries are records held by MedtechLedger for P990019. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P990019
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Sun Pharmaceutical Industries, Inc. | PMA supplement | Nov 2, 2026 | FDA |
Regulatory context
An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Sun Pharmaceutical Industries, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 29 Dunham Rd., Billerica, MA, 01821
Sources and methodology
- Original FDA record: P990019
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records